Table 1.
Proposed Quality Indicators for Colonoscopy – ASGE/ACG 20069
| Quality indicator | Grade of recommendation |
|---|---|
| Pre-procedure | |
| Appropriate indication | 1C+ |
| Informed consent including discussion of risks | 3 |
| Use of post-polypectomy and post-cancer resection surveillance intervals | 1A |
| Use of IBD disease surveillance intervals | 2C |
| Documentation of quality of bowel preparation in note | 2C |
| Intra-procedure | |
| Cecal intubation rates including photo documentation of landmark in note | 1C |
| Adenoma detection during screening | 1C |
| Withdrawal time: mean >6 minutes in normals exams | 2C |
| Biopsy specimens in patients with chronic diarrhea | 2C |
| Number and distribution of biopsy specimens in IBD surveillance | 1C |
| Endoscopic resection attempted for pedunculated polyps and sessile polyps <2 cm | 3 |
| Post-procedure | |
| Incidence of perforation | 2C |
| Incidence of post-polypectomy bleeding | 2C |
| Pot-polypectomy bleeding managed non-operatively | 1C |
Adapted by permission from Macmillan Publishers Ltd: American Journal of Gastroenterology (Rex DK, Petrini JL, Baron TH, et al. Quality indicators for colonoscopy. Am J Gastroenterol 2006;101:873–85), copyright 2006.
1A = Strong: clear benefit, supported by randomized trials without important limitations
1C+ =Strong: clear benefit, supported by overwhelming evidence from observational studies
1C = Intermediate: clear benefit, supported by observational studies
2C = Very weak: unclear benefit, supported by observational studies
3 = Weak: unclear benefit, expert opinion only